<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 46-years-old woman was admitted with <z:hpo ids='HP_0000979'>purpura</z:hpo>, nasal <z:mp ids='MP_0001914'>bleeding</z:mp>, gum <z:mp ids='MP_0001914'>bleeding</z:mp>, gross <z:hpo ids='HP_0000790'>hematuria</z:hpo>, <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo>, and <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The data of her peripheral blood were as follows: WBC 17,500/microliters, Hb 5.1 g/dl, PLT 0.3 x 10(4)/microliters, LDH 924 IU/l </plain></SENT>
<SENT sid="2" pm="."><plain>Primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> was diagnosed because of bone marrow <z:mp ids='MP_0003045'>fibrosis</z:mp> and <z:hpo ids='HP_0001978'>extramedullary hematopoiesis</z:hpo> of the spleen </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, she revealed marked <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and no response to platelet transfusion, so association of <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>) was considered </plain></SENT>
<SENT sid="4" pm="."><plain>Though she was treated with high dose predonisolone, high dose gamma-globulin, and splenectomy, no hematological improvement was achieved </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of <z:chebi fb="2" ids="2948">azathioprine</z:chebi> (100 mg/day) was begun and 2 weeks later, her white blood cell count was approximately 10,000/microliters, the platelet count 2.0 x 10(4)/microliters, and no <z:mp ids='MP_0001914'>bleeding</z:mp> focus was found </plain></SENT>
<SENT sid="6" pm="."><plain>Four weeks later, her <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> content was 13.0 g/dl without blood transfusion </plain></SENT>
<SENT sid="7" pm="."><plain>The diagnosis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, rather than <z:chebi fb="0" ids="16039">ITP</z:chebi>, was made because of anticardiolipin-beta 2GPI complex antibody and <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>It is interesting that <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi> was effective both in primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> and in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>